Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) using a human norepinephrine transporter (hNET) reporter gene

PURPOSE: Oncolytic viral therapy continues to be investigated for the treatment of cancer and future studies in patients would benefit greatly from a non-invasive modality for assessing virus dissemination, targeting and persistence. The purpose of this study was to determine if a genetically modifi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Brader, P, Kelly, KJ, Chen, N, Yu, YA, Zhang, Q, Zanzonico, P, Burnazi, EM, Ghani, ER, Serganova, I, Hricak, H, Szalay, AA, Fong, Y, Blasberg, R
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5503149/
https://ncbi.nlm.nih.gov/pubmed/19470726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-3236
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados